Skip to main content
Log in

CNS adverse events with antimalarial drugs — assess the risk:benefit ratio individually

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Phillips-Howard P, ter Kuile FO. CNS adverse events associated with antimalarial agents. Drug Saf 1995 Jun; 12(6): 370–83

    Article  PubMed  CAS  Google Scholar 

  2. Nosten F, Price RN. New antimalarials: a risk-benefit analysis. Drug Saf 1995 Apr; 12(4): 264–73

    Article  PubMed  CAS  Google Scholar 

  3. Luzzi GA, Peto TEA. Adverse effects of antimalarials: an update. Drug Saf 1993 Apr; 8(4): 295–311

    Article  PubMed  CAS  Google Scholar 

  4. Minimising the adverse effects of antimalarials. Drug Ther Perspect 1993 Sep l3; 2(5): 14–16

    Article  Google Scholar 

  5. Fish DR, Espir MLE. Convulsions associated with prophylactic anti-malarial drugs: implications for people with epilepsy. BMJ 1988 Aug 20–27; 297: 525–7

    Article  Google Scholar 

  6. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993 May 22; 341: 1299–303

    Article  PubMed  CAS  Google Scholar 

  7. Akhtar S, Mukherjee S. Chloroquine induced mania. Int J Psychiatry Med 1993; 23: 349–56

    Article  PubMed  CAS  Google Scholar 

  8. Bern JL, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 1992 Jun; 95: 167–79

    Google Scholar 

  9. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991; 45(1): 86–91

    PubMed  CAS  Google Scholar 

  10. Cook GC. Adverse effects of chemotherapeutic agents used in tropical medicine. Drug Saf 1995 Jul; 13(1): 31–45

    Article  PubMed  CAS  Google Scholar 

  11. British National Formulary No. 29. London: The Pharmaceutical Press, 1995; 258-65

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CNS adverse events with antimalarial drugs — assess the risk:benefit ratio individually. Drugs Ther. Perspect 6, 11–13 (1995). https://doi.org/10.2165/00042310-199506070-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506070-00005

Navigation